
Doctors may have to use last year’s stock of the H1N1 vaccine Pandemrix as the government admits there are some …

The European Medicines Agency has launched a review of GlaxoSmithKline’s influenza vaccine Pandemrix. The European Commission asked the EMA to …

The world is no longer in the grips of an H1N1 pandemic and the virus has run its course according …

The US and India are looking to establish closer ties between their top medical schools. The initiative was one of …

The UK government has agreed a deal with GlaxoSmithKine on surplus supplies of its H1N1 vaccine Pandemrix. The Department of …
The US Food and Drug Administration has issued a new guidance document designed to help encourage the adoption of cell-based …

The government has warned against complacency over swine flu as it released figures showing UK cases had fallen to one …

A European politician has criticised the pharmaceutical industry for creating public health scares and profiting from them. Dr Wolfgang Wodarg …

The Germany Ministry of Health has cut its order for GlaxoSmithKline’s swine flu vaccine Pandemrix by 30%. The pharma company …
Novartis’ swine flu vaccine Celtura has been approved in Germany, its first market, in what is a major milestone for …
The UK's swine flu vaccination programme began today with NHS hospitals offering the jabs to frontline healthcare workers and patients …
GSK has agreed another 22 government orders for its adjuvanted swine-flu vaccine – an extra 149 million doses on top …
Baxter’s swine-flu vaccine is third in line for approval in Europe, behind already approved rivals from GSK and Novartis.Regulatory advisors …
Sanofi Pasteur, the vaccines division of the Sanofi-Aventis Group, has said its swine flu vaccine is effective after a single …
The UK has commenced a two-week swine flu vaccine trial, a month ahead of its planned programme to vaccinate 11 …